Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Genpact LTDG · Entity 3760 | Director · President and CEO | September 14, 2026 | September 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Genpact LTD
Report date September 14, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 501,114 |
Reported balance
After 2026-09-14 transaction · row 1
1 source rowRow 1 · 2026-09-14 · Sale · Disposed 10,000 · Balance 501,114 F1: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $36.790 to $36.795. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
Filing footnotes · ownership attribution and instrument terms
F1: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $36.790 to $36.795. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2026 Filed Sep 16, 2026 20:01 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 10,000 | $36.79 | $367,900.00 |
DisclosureSEC source: 0001768217-26-000011 · wk-form4_1789588893.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 501,114 F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $36.790 to $36.795. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:04 UTC | Genpact LTD G · Entity 3760 | Tax withholdingCommon Shares | 13,893 | $38.92 | $540,715.56 |
DisclosureSEC source: 0001768217-26-000009 · wk-form4_1773345874.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 511,114 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of performance share units granted on March 15, 2023 under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 21:43 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,800 | $0.00 Strike: $27.65 | $0.00 |
DisclosureSEC source: 0001768217-26-000006 · wk-form4_1772747004.xml · derivative · entry 4 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,800 shares Expires 2026-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested 50% on January 10, 2019 and the remainder on January 10, 2021. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 21:43 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 2,800 | $40.77 | $114,156.00 |
DisclosureSEC source: 0001768217-26-000006 · wk-form4_1772747004.xml · nonDerivative · entry 3 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525,007 F3 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $40.74 to $40.771. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 21:43 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 2,800 | $27.65 | $77,420.00 |
DisclosureSEC source: 0001768217-26-000006 · wk-form4_1772747004.xml · nonDerivative · entry 2 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 527,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 21:43 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 27,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001768217-26-000006 · wk-form4_1772747004.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525,007 F1 · shares: The reporting person was granted performance share units (PSUs) on March 15, 2023 that were subject to performance conditions which have been satisfied. Each PSU represents the contingent right to receive one common share. The PSUs will vest on March 10, 2026 subject to the reporting person's continued service through such date. F2 · balance_after: Includes 587 shares acquired under the Genpact Employee Stock Purchase Plan (ESPP) since the reporting person's Form 4 filed on February 3, 2026. The reporting person currently holds a total of 8,962 shares under the ESPP. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:02 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 106,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001768217-26-000004 · wk-form4_1770152576.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 497,260 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 10, 2026 Filed Jan 14, 2026 02:36 UTC | Genpact LTD G · Entity 3760 | Tax withholdingCommon Shares | 29,691 | $48.24 | $1,432,293.84 |
DisclosureSEC source: 0001768217-26-000002 · wk-form4_1768358176.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 390,685 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan and exempt under Rule 16b-3. Read SEC document |
| December 17, 2025 Filed Dec 19, 2025 21:16 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 125,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001768217-25-000007 · wk-form4_1766179012.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 420,376 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of December 17, 2026, December 17, 2027 and December 17, 2028, subject to the reporting person's continued service through each vesting date. Read SEC document |
| September 11, 2025 Filed Sep 15, 2025 20:10 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $27.65 | $0.00 |
DisclosureSEC source: 0001768217-25-000004 · wk-form4_1757967049.xml · derivative · entry 4 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,800 Underlying: Common Shares · 40,000 shares Expires 2026-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested 50% on January 10, 2019 and the remainder on January 10, 2021. Read SEC document |
| September 11, 2025 Filed Sep 15, 2025 20:10 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 40,000 | $43.35 | $1,734,000.00 |
DisclosureSEC source: 0001768217-25-000004 · wk-form4_1757967049.xml · nonDerivative · entry 3 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,246 F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.29 to $43.42. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| September 11, 2025 Filed Sep 15, 2025 20:10 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 40,000 | $27.65 | $1,106,000.00 |
DisclosureSEC source: 0001768217-25-000004 · wk-form4_1757967049.xml · nonDerivative · entry 2 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 335,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2025 Filed Sep 15, 2025 20:10 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 15,000 | $43.39 | $650,850.00 |
DisclosureSEC source: 0001768217-25-000004 · wk-form4_1757967049.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,246 F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.39 to $43.40. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| March 13, 2025 Filed Mar 14, 2025 20:04 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 13,600 | $0.00 Strike: $27.65 | $0.00 |
DisclosureSEC source: 0001398659-25-000053 · wk-form4_1741982638.xml · derivative · entry 3 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,800 Underlying: Common Shares · 13,600 shares Expires 2026-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested 50% on January 10, 2019 and the remainder on January 10, 2021. Read SEC document |
| March 13, 2025 Filed Mar 14, 2025 20:04 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 13,600 | $48.89 | $664,904.00 |
DisclosureSEC source: 0001398659-25-000053 · wk-form4_1741982638.xml · nonDerivative · entry 2 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 310,246 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024. F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $48.70 to $49.13. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| March 13, 2025 Filed Mar 14, 2025 20:04 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 13,600 | $27.65 | $376,040.00 |
DisclosureSEC source: 0001398659-25-000053 · wk-form4_1741982638.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 323,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:10 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 78,782 | $0.00 | $0.00 |
DisclosureSEC source: 0001398659-25-000049 · wk-form4_1741896603.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,246 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2026, January 10, 2027 and January 10, 2028, subject to the reporting person's continued service through each vesting date. F2 · balance_after: Includes 521 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on January 14, 2025. The reporting person currently holds a total of 8,375 shares under the ESPP. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 21:39 UTC | Genpact LTD G · Entity 3760 | Tax withholdingCommon Shares | 36,461 | $43.34 | $1,580,219.74 |
DisclosureSEC source: 0001398659-25-000018 · wk-form4_1736890762.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,943 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted share units and performance share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan and exempt under Rule 16b-3. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:01 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 13,600 | $0.00 Strike: $27.65 | $0.00 |
DisclosureSEC source: 0001398659-24-000115 · wk-form4_1734469286.xml · derivative · entry 3 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,400 Underlying: Common Shares · 13,600 shares Expires 2026-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested 50% on January 10, 2019 and the remainder on January 10, 2021. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:01 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 13,600 | $44.60 | $606,560.00 |
DisclosureSEC source: 0001398659-24-000115 · wk-form4_1734469286.xml · nonDerivative · entry 2 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 267,404 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024. F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.47 to $44.78. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:01 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 13,600 | $27.65 | $376,040.00 |
DisclosureSEC source: 0001398659-24-000115 · wk-form4_1734469286.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 281,004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024. Read SEC document |
| November 25, 2024 Filed Nov 26, 2024 21:21 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 9,000 | $46.40 | $417,600.00 |
DisclosureSEC source: 0001398659-24-000113 · wk-form4_1732656095.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,404 F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $46.40 to $46.43. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 20:08 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 7,000 | $38.54 | $269,786.30 |
DisclosureSEC source: 0001398659-24-000094 · wk-form4_1726258122.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,404 F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $38.54 to $38.55. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 21:00 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 96,848 | $0.00 | $0.00 |
DisclosureSEC source: 0001398659-24-000046 · wk-form4_1710536417.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,404 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2025, January 10, 2026 and January 10, 2027, subject to the reporting person's continued service through each vesting date. F2 · balance_after: Includes 719 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on January 12, 2024. The reporting person currently holds a total of 7,854 shares under the ESPP. Read SEC document |
| January 10, 2024 Filed Jan 12, 2024 22:12 UTC | Genpact LTD G · Entity 3760 | Tax withholdingCommon Shares | 25,531 | $34.27 | $874,947.37 |
DisclosureSEC source: 0001398659-24-000014 · wk-form4_1705097528.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,837 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted share units and performance share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan and exempt under Rule 16b-3. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:07 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 15,791 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-005248 · doc1.xml · nonDerivative · entry 2 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,368 F2 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2024, January 10, 2025 and January 10, 2026, subject to the reporting person's continued service through each vesting date. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:07 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 40,249 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-005248 · doc1.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,577 F1 · shares: The reporting person was granted performance share units (PSUs) on March 20, 2022 that were subject to performance conditions which have been satisfied. Each PSU represents the contingent right to receive one common share. The PSUs will vest on January 10, 2025 subject to the reporting person's continued service through such date. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 20:09 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 22,280 | $0.00 Strike: $19.35 | $0.00 |
DisclosureSEC source: 0001567619-23-005103 · doc1.xml · derivative · entry 3 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 22,280 shares Expires 2023-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested 50% on January 10, 2016 and 50% on January 10, 2018. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 20:09 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 22,280 | $44.40 | $989,289.93 |
DisclosureSEC source: 0001567619-23-005103 · doc1.xml · nonDerivative · entry 2 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,328 F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.15 to $44.62. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 20:09 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 22,280 | $19.35 | $431,118.00 |
DisclosureSEC source: 0001567619-23-005103 · doc1.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:08 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,554 | $0.00 Strike: $19.35 | $0.00 |
DisclosureSEC source: 0001567619-23-004663 · doc1.xml · derivative · entry 6 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,280 Underlying: Common Shares · 2,554 shares Expires 2023-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested 50% on January 10, 2016 and 50% on January 10, 2018. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:08 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 17,446 | $0.00 Strike: $19.35 | $0.00 |
DisclosureSEC source: 0001567619-23-004663 · doc1.xml · derivative · entry 5 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,834 Underlying: Common Shares · 17,446 shares Expires 2023-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested 50% on January 10, 2016 and 50% on January 10, 2018. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:08 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 2,554 | $47.50 | $121,316.53 |
DisclosureSEC source: 0001567619-23-004663 · doc1.xml · nonDerivative · entry 4 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,328 F3 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $47.50 to $47.51. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:08 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 2,554 | $19.35 | $49,419.90 |
DisclosureSEC source: 0001567619-23-004663 · doc1.xml · nonDerivative · entry 3 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:08 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 17,446 | $47.31 | $825,361.54 |
DisclosureSEC source: 0001567619-23-004663 · doc1.xml · nonDerivative · entry 2 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,328 F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $47.29 to $47.375. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:08 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 17,446 | $19.35 | $337,580.10 |
DisclosureSEC source: 0001567619-23-004663 · doc1.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 540 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on February 23, 2023. The reporting person currently holds a total of 7,135 shares under the ESPP. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:08 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $19.35 | $0.00 |
DisclosureSEC source: 0001567619-23-003619 · doc1.xml · derivative · entry 3 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,280 Underlying: Common Shares · 25,000 shares Expires 2023-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested 50% on January 10, 2016 and 50% on January 10, 2018. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:08 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 25,000 | $47.99 | $1,199,657.50 |
DisclosureSEC source: 0001567619-23-003619 · doc1.xml · nonDerivative · entry 2 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,788 F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $47.95 to $48.26. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:08 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 25,000 | $19.35 | $483,750.00 |
DisclosureSEC source: 0001567619-23-003619 · doc1.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 21:13 UTC | Genpact LTD G · Entity 3760 | Tax withholdingCommon Shares | 9,441 | $46.77 | $441,555.57 |
DisclosureSEC source: 0001567619-23-000887 · doc1.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,788 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of performance share units granted on February 19, 2020 under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:04 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 7,000 | $46.09 | $322,647.50 |
DisclosureSEC source: 0001567619-22-017225 · doc1.xml · nonDerivative · entry 2 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,229 F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $46.08 to $46.145. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:04 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 3,726 | $46.37 | $172,760.09 |
DisclosureSEC source: 0001567619-22-017225 · doc1.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,229 F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $46.36 to $46.40. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 20:12 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 8,730 | $47.40 | $413,774.94 |
DisclosureSEC source: 0001567619-22-017120 · doc1.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,955 F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $47.265 to $47.45. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| August 26, 2022 Filed Aug 30, 2022 20:09 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 10,000 | $47.35 | $473,542.00 |
DisclosureSEC source: 0001567619-22-016832 · doc1.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,685 F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $47.03 to $47.93. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:18 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 52,883 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-006639 · doc1.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,685 F1 · shares: The reporting person was granted performance share units (PSUs) on March 4, 2021 that were subject to performance conditions which have been satisfied. Each PSU represents the contingent right to receive one common share. The PSUs will vest on January 10, 2024 subject to the reporting person's continued service through such date. F2 · balance_after: Includes 521 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on January 12, 2022. The reporting person currently holds a total of 6,595 shares under the ESPP. Read SEC document |
| January 12, 2022 Filed Jan 12, 2022 21:18 UTC | Genpact LTD G · Entity 3760 | Tax withholdingCommon Shares | 36,987 | $52.12 | $1,927,762.44 |
DisclosureSEC source: 0001567619-22-001104 · doc1.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,281 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of performance share units granted on February 13, 2019 under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 21:18 UTC | Genpact LTD G · Entity 3760 | GrantEmployee Stock Option (Right to Buy) · Derivative | 103,412 | $0.00 Strike: $52.12 | $0.00 |
DisclosureSEC source: 0001567619-22-001104 · doc1.xml · derivative · entry 2 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,412 Underlying: Common Shares · 103,412 shares Expires 2032-01-09 F2 · derivative.exercise_date: The option vests 50% on January 10, 2025 and 50% on January 10, 2027. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 21:05 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 5,000 | $50.73 | $253,625.00 |
DisclosureSEC source: 0001567619-21-022096 · doc1.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,268 Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 20:19 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 5,000 | $50.18 | $250,910.00 |
DisclosureSEC source: 0001567619-21-017193 · doc1.xml · nonDerivative · entry 1 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,268 Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:14 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 1,000 | $42.80 | $42,800.00 |
DisclosureSEC source: 0001567619-21-006403 · doc1.xml · nonDerivative · entry 2 Kalra Balkrishan · CIK 0001768217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,268 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.